APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cabozantinib Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cabozantinib Drug Industry Growth and Trends Forecast to 2032

Report ID 17397362012 January 202690 pages

Choose your research edition.

Industry ResearchCabozantinib Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Cabozantinib Drug Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Cabozantinib Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cabozantinib Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cabozantinib Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cabozantinib Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cabozantinib Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cabozantinib Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cabozantinib Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cabozantinib Drug include BDR Pharma, Beacon Pharmaceuticals, Cipla, Elemento Pharma, Exelixis, MSN Labs, Stada Arzneimittel, Zydus and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cabozantinib Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cabozantinib Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cabozantinib Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cabozantinib Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cabozantinib Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cabozantinib Drug Market by Company

BDR Pharma

Beacon Pharmaceuticals

Cipla

Elemento Pharma

Exelixis

MSN Labs

Stada Arzneimittel

Zydus

Teva

Cabozantinib Drug Segment by Type

Tablets

Capsules

Cabozantinib Drug Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Cabozantinib Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cabozantinib Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cabozantinib Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cabozantinib Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cabozantinib Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cabozantinib Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablets Table 2. Major Company of Capsules Table 3. Global Cabozantinib Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cabozantinib Drug Sales by Type (2021-2026) & (K Units) Table 5. Global Cabozantinib Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cabozantinib Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cabozantinib Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Cabozantinib Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global Cabozantinib Drug Sales by Type (2027-2032) & (K Units) Table 10. Global Cabozantinib Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cabozantinib Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cabozantinib Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Cabozantinib Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America Cabozantinib Drug Sales by Type (2021-2026) & (K Units) Table 15. North America Cabozantinib Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cabozantinib Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe Cabozantinib Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cabozantinib Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Cabozantinib Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cabozantinib Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America Cabozantinib Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cabozantinib Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Cabozantinib Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Cabozantinib Drug Industry Trends Table 25. Cabozantinib Drug Industry Drivers Table 26. Cabozantinib Drug Industry Opportunities and Challenges Table 27. Cabozantinib Drug Industry Restraints Table 28. Global Cabozantinib Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cabozantinib Drug Revenue Market Share by Company (2021-2026) Table 30. Global Cabozantinib Drug Sales by Company (2021-2026) & (K Units) Table 31. Global Cabozantinib Drug Sales Share by Company (2021-2026) Table 32. Global Cabozantinib Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Cabozantinib Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cabozantinib Drug Major Company Production Sites and Headquarters Table 35. Global Cabozantinib Drug Company, Product Type & Application Table 36. Global Cabozantinib Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cabozantinib Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cabozantinib Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cabozantinib Drug Sales by Region (2021-2026) & (K Units) Table 41. Global Cabozantinib Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cabozantinib Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cabozantinib Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Cabozantinib Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Cabozantinib Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Cabozantinib Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cabozantinib Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cabozantinib Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Cabozantinib Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Cabozantinib Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cabozantinib Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Cabozantinib Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cabozantinib Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cabozantinib Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Cabozantinib Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Cabozantinib Drug Sales by Application (2027-2032) & (K Units) Table 57. Global Cabozantinib Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cabozantinib Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cabozantinib Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Cabozantinib Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America Cabozantinib Drug Sales by Application (2021-2026) & (K Units) Table 62. North America Cabozantinib Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cabozantinib Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe Cabozantinib Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cabozantinib Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Cabozantinib Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cabozantinib Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America Cabozantinib Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cabozantinib Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Cabozantinib Drug Sales by Application (2021-2026) & (US$ Million) Table 71. BDR Pharma Company Information Table 72. BDR Pharma Business Overview Table 73. BDR Pharma Cabozantinib Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. BDR Pharma Cabozantinib Drug Product Portfolio Table 75. BDR Pharma Recent Development Table 76. Beacon Pharmaceuticals Company Information Table 77. Beacon Pharmaceuticals Business Overview Table 78. Beacon Pharmaceuticals Cabozantinib Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Beacon Pharmaceuticals Cabozantinib Drug Product Portfolio Table 80. Beacon Pharmaceuticals Recent Development Table 81. Cipla Company Information Table 82. Cipla Business Overview Table 83. Cipla Cabozantinib Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Cipla Cabozantinib Drug Product Portfolio Table 85. Cipla Recent Development Table 86. Elemento Pharma Company Information Table 87. Elemento Pharma Business Overview Table 88. Elemento Pharma Cabozantinib Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Elemento Pharma Cabozantinib Drug Product Portfolio Table 90. Elemento Pharma Recent Development Table 91. Exelixis Company Information Table 92. Exelixis Business Overview Table 93. Exelixis Cabozantinib Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Exelixis Cabozantinib Drug Product Portfolio Table 95. Exelixis Recent Development Table 96. MSN Labs Company Information Table 97. MSN Labs Business Overview Table 98. MSN Labs Cabozantinib Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. MSN Labs Cabozantinib Drug Product Portfolio Table 100. MSN Labs Recent Development Table 101. Stada Arzneimittel Company Information Table 102. Stada Arzneimittel Business Overview Table 103. Stada Arzneimittel Cabozantinib Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Stada Arzneimittel Cabozantinib Drug Product Portfolio Table 105. Stada Arzneimittel Recent Development Table 106. Zydus Company Information Table 107. Zydus Business Overview Table 108. Zydus Cabozantinib Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Zydus Cabozantinib Drug Product Portfolio Table 110. Zydus Recent Development Table 111. Teva Company Information Table 112. Teva Business Overview Table 113. Teva Cabozantinib Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Teva Cabozantinib Drug Product Portfolio Table 115. Teva Recent Development Table 116. North America Cabozantinib Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Cabozantinib Drug Sales by Country (2021-2026) & (K Units) Table 118. North America Cabozantinib Drug Sales Market Share by Country (2021-2026) Table 119. North America Cabozantinib Drug Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Cabozantinib Drug Sales Market Share Forecast by Country (2027-2032) Table 121. North America Cabozantinib Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Cabozantinib Drug Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Cabozantinib Drug Market Share by Country (2021-2026) Table 124. North America Cabozantinib Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Cabozantinib Drug Market Share Forecast by Country (2027-2032) Table 126. Europe Cabozantinib Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Cabozantinib Drug Sales by Country (2021-2026) & (K Units) Table 128. Europe Cabozantinib Drug Sales Market Share by Country (2021-2026) Table 129. Europe Cabozantinib Drug Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Cabozantinib Drug Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Cabozantinib Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Cabozantinib Drug Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Cabozantinib Drug Market Share by Country (2021-2026) Table 134. Europe Cabozantinib Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Cabozantinib Drug Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Cabozantinib Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Cabozantinib Drug Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Cabozantinib Drug Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Cabozantinib Drug Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Cabozantinib Drug Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Cabozantinib Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Cabozantinib Drug Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Cabozantinib Drug Market Share by Country (2021-2026) Table 144. Asia-Pacific Cabozantinib Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Cabozantinib Drug Market Share Forecast by Country (2027-2032) Table 146. Latin America Cabozantinib Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Cabozantinib Drug Sales by Country (2021-2026) & (K Units) Table 148. Latin America Cabozantinib Drug Sales Market Share by Country (2021-2026) Table 149. Latin America Cabozantinib Drug Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Cabozantinib Drug Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Cabozantinib Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Cabozantinib Drug Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Cabozantinib Drug Market Share by Country (2021-2026) Table 154. Latin America Cabozantinib Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Cabozantinib Drug Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Cabozantinib Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Cabozantinib Drug Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Cabozantinib Drug Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Cabozantinib Drug Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Cabozantinib Drug Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Cabozantinib Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Cabozantinib Drug Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Cabozantinib Drug Market Share by Country (2021-2026) Table 164. Middle East and Africa Cabozantinib Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Cabozantinib Drug Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Cabozantinib Drug Distributors List Table 169. Cabozantinib Drug Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Cabozantinib Drug Image Figure 2. Global Cabozantinib Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cabozantinib Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Cabozantinib Drug Sales (2021-2032) & (K Units) Figure 5. Tablets Image Figure 6. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsules Image Figure 8. Global Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Cabozantinib Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cabozantinib Drug Market Share by Type 2025 VS 2032 Figure 11. North America Cabozantinib Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Cabozantinib Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Cabozantinib Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cabozantinib Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cabozantinib Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cabozantinib Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cabozantinib Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cabozantinib Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cabozantinib Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cabozantinib Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cabozantinib Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Cabozantinib Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cabozantinib Drug Market Share by Application 2025 VS 2032 Figure 31. North America Cabozantinib Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Cabozantinib Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Cabozantinib Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Cabozantinib Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Cabozantinib Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Cabozantinib Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Cabozantinib Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Cabozantinib Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Cabozantinib Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Cabozantinib Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Cabozantinib Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Cabozantinib Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Cabozantinib Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Cabozantinib Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cabozantinib Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Cabozantinib Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cabozantinib Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Cabozantinib Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cabozantinib Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Cabozantinib Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cabozantinib Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Cabozantinib Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cabozantinib Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Cabozantinib Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cabozantinib Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Cabozantinib Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cabozantinib Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Cabozantinib Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cabozantinib Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Cabozantinib Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Cabozantinib Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Cabozantinib Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • BDR Pharma
  • Beacon Pharmaceuticals
  • Cipla
  • Elemento Pharma
  • Exelixis
  • MSN Labs
  • Stada Arzneimittel
  • Zydus
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cabozantinib Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cabozantinib Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cabozantinib Drug Market by Type
  6. 1.3.1 Tablets
  7. 1.3.2 Capsules
  8. 1.4 Global Cabozantinib Drug Market Size by Type
  9. 1.4.1 Global Cabozantinib Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cabozantinib Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cabozantinib Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cabozantinib Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cabozantinib Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cabozantinib Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cabozantinib Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cabozantinib Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cabozantinib Drug Industry Trends
  2. 2.2 Cabozantinib Drug Industry Drivers
  3. 2.3 Cabozantinib Drug Industry Opportunities and Challenges
  4. 2.4 Cabozantinib Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cabozantinib Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Cabozantinib Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Cabozantinib Drug Price (2021-2026)
  4. 3.4 Global Cabozantinib Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cabozantinib Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Cabozantinib Drug Company, Product Type & Application
  7. 3.7 Global Cabozantinib Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cabozantinib Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cabozantinib Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cabozantinib Drug Tier 1, Tier 2, and Tier 3
4 Cabozantinib Drug Regional Status and Outlook
  1. 4.1 Global Cabozantinib Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cabozantinib Drug Historic Market Size by Region
  3. 4.2.1 Global Cabozantinib Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cabozantinib Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cabozantinib Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cabozantinib Drug Forecasted Market Size by Region
  7. 4.3.1 Global Cabozantinib Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cabozantinib Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cabozantinib Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cabozantinib Drug by Application
  1. 5.1 Cabozantinib Drug Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Cabozantinib Drug Market Size by Application
  6. 5.2.1 Global Cabozantinib Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cabozantinib Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cabozantinib Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cabozantinib Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cabozantinib Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cabozantinib Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cabozantinib Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cabozantinib Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BDR Pharma
  2. 6.1.1 BDR Pharma Company Information
  3. 6.1.2 BDR Pharma Business Overview
  4. 6.1.3 BDR Pharma Cabozantinib Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BDR Pharma Cabozantinib Drug Product Portfolio
  6. 6.1.5 BDR Pharma Recent Developments
  7. 6.2 Beacon Pharmaceuticals
  8. 6.2.1 Beacon Pharmaceuticals Company Information
  9. 6.2.2 Beacon Pharmaceuticals Business Overview
  10. 6.2.3 Beacon Pharmaceuticals Cabozantinib Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Beacon Pharmaceuticals Cabozantinib Drug Product Portfolio
  12. 6.2.5 Beacon Pharmaceuticals Recent Developments
  13. 6.3 Cipla
  14. 6.3.1 Cipla Company Information
  15. 6.3.2 Cipla Business Overview
  16. 6.3.3 Cipla Cabozantinib Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cipla Cabozantinib Drug Product Portfolio
  18. 6.3.5 Cipla Recent Developments
  19. 6.4 Elemento Pharma
  20. 6.4.1 Elemento Pharma Company Information
  21. 6.4.2 Elemento Pharma Business Overview
  22. 6.4.3 Elemento Pharma Cabozantinib Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Elemento Pharma Cabozantinib Drug Product Portfolio
  24. 6.4.5 Elemento Pharma Recent Developments
  25. 6.5 Exelixis
  26. 6.5.1 Exelixis Company Information
  27. 6.5.2 Exelixis Business Overview
  28. 6.5.3 Exelixis Cabozantinib Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Exelixis Cabozantinib Drug Product Portfolio
  30. 6.5.5 Exelixis Recent Developments
  31. 6.6 MSN Labs
  32. 6.6.1 MSN Labs Company Information
  33. 6.6.2 MSN Labs Business Overview
  34. 6.6.3 MSN Labs Cabozantinib Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 MSN Labs Cabozantinib Drug Product Portfolio
  36. 6.6.5 MSN Labs Recent Developments
  37. 6.7 Stada Arzneimittel
  38. 6.7.1 Stada Arzneimittel Company Information
  39. 6.7.2 Stada Arzneimittel Business Overview
  40. 6.7.3 Stada Arzneimittel Cabozantinib Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Stada Arzneimittel Cabozantinib Drug Product Portfolio
  42. 6.7.5 Stada Arzneimittel Recent Developments
  43. 6.8 Zydus
  44. 6.8.1 Zydus Company Information
  45. 6.8.2 Zydus Business Overview
  46. 6.8.3 Zydus Cabozantinib Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zydus Cabozantinib Drug Product Portfolio
  48. 6.8.5 Zydus Recent Developments
  49. 6.9 Teva
  50. 6.9.1 Teva Company Information
  51. 6.9.2 Teva Business Overview
  52. 6.9.3 Teva Cabozantinib Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teva Cabozantinib Drug Product Portfolio
  54. 6.9.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Cabozantinib Drug Sales by Country
  2. 7.1.1 North America Cabozantinib Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cabozantinib Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Cabozantinib Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cabozantinib Drug Market Size by Country
  6. 7.2.1 North America Cabozantinib Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cabozantinib Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Cabozantinib Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cabozantinib Drug Sales by Country
  2. 8.1.1 Europe Cabozantinib Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cabozantinib Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Cabozantinib Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cabozantinib Drug Market Size by Country
  6. 8.2.1 Europe Cabozantinib Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cabozantinib Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cabozantinib Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cabozantinib Drug Sales by Country
  2. 9.1.1 Asia-Pacific Cabozantinib Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cabozantinib Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cabozantinib Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cabozantinib Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Cabozantinib Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cabozantinib Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cabozantinib Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cabozantinib Drug Sales by Country
  2. 10.1.1 South America Cabozantinib Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cabozantinib Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Cabozantinib Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cabozantinib Drug Market Size by Country
  6. 10.2.1 South America Cabozantinib Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cabozantinib Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Cabozantinib Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cabozantinib Drug Sales by Country
  2. 11.1.1 Middle East and Africa Cabozantinib Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cabozantinib Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cabozantinib Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cabozantinib Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Cabozantinib Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cabozantinib Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cabozantinib Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cabozantinib Drug Value Chain Analysis
  2. 12.1.1 Cabozantinib Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cabozantinib Drug Production Mode & Process
  7. 12.2 Cabozantinib Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cabozantinib Drug Distributors
  10. 12.2.3 Cabozantinib Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst